| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CSTL | Common Stock | Sale | $200,851 | -7,445 | -3.7% | $26.98 | 192,094 | 01 Feb 2023 | By LLC | F1, F2, F3 |
| transaction | CSTL | Common Stock | Sale | $66,932 | -2,481 | -2.5% | $26.98 | 95,299 | 01 Feb 2023 | By Daniel Bradbury Irrecovable Descendant's Trust | F1, F2, F4 |
| transaction | CSTL | Common Stock | Sale | $66,959 | -2,482 | -2.5% | $26.98 | 95,323 | 01 Feb 2023 | By Annette Bradbury Irrecovable Descendant's Trust | F1, F2, F5 |
| transaction | CSTL | Common Stock | Sale | $122,451 | -4,451 | -2.3% | $27.51 | 187,643 | 01 Feb 2023 | By LLC | F1, F3, F6 |
| transaction | CSTL | Common Stock | Sale | $40,826 | -1,484 | -1.6% | $27.51 | 93,815 | 01 Feb 2023 | By Daniel Bradbury Irrecovable Descendant's Trust | F1, F4, F6 |
| transaction | CSTL | Common Stock | Sale | $40,799 | -1,483 | -1.6% | $27.51 | 93,840 | 01 Feb 2023 | By Annette Bradbury Irrecovable Descendant's Trust | F1, F5, F6 |
| transaction | CSTL | Common Stock | Sale | $76,623 | -2,684 | -1.4% | $28.55 | 184,959 | 02 Feb 2023 | By LLC | F1, F3, F7 |
| transaction | CSTL | Common Stock | Sale | $25,550 | -895 | -0.95% | $28.55 | 92,920 | 02 Feb 2023 | By Daniel Bradbury Irrecovable Descendant's Trust | F1, F4, F7 |
| transaction | CSTL | Common Stock | Sale | $25,550 | -895 | -0.95% | $28.55 | 92,945 | 02 Feb 2023 | By Annette Bradbury Irrecovable Descendant's Trust | F1, F5, F7 |
| transaction | CSTL | Common Stock | Sale | $12,231 | -420 | -0.23% | $29.12 | 184,539 | 02 Feb 2023 | By LLC | F1, F3, F8 |
| transaction | CSTL | Common Stock | Sale | $4,077 | -140 | -0.15% | $29.12 | 92,780 | 02 Feb 2023 | By Daniel Bradbury Irrecovable Descendant's Trust | F1, F4, F8 |
| transaction | CSTL | Common Stock | Sale | $4,077 | -140 | -0.15% | $29.12 | 92,805 | 02 Feb 2023 | By Annette Bradbury Irrecovable Descendant's Trust | F1, F5, F8 |
| holding | CSTL | Common Stock | 830 | 01 Feb 2023 | Direct |
| Id | Content |
|---|---|
| F1 | The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC on November 23, 2022. |
| F2 | This transaction was executed in multiple trades at prices ranging from $26.320 to $27.315, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. |
| F4 | Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. |
| F5 | Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. |
| F6 | This transaction was executed in multiple trades at prices ranging from $27.320 to $27.905, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | This transaction was executed in multiple trades at prices ranging from $28.100 to $29.035, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F8 | This transaction was executed in multiple trades at prices ranging from $29.105 to $29.145, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |